Next Article in Journal
Precision Revisited: Targeting Microcephaly Kinases in Brain Tumors
Next Article in Special Issue
Nitropyridine-1-Oxides as Excellent π-Hole Donors: Interplay between σ-Hole (Halogen, Hydrogen, Triel, and Coordination Bonds) and π-Hole Interactions
Previous Article in Journal
Modeling of Protein–Protein Interactions in Cytokinin Signal Transduction
Article Menu
Issue 9 (May-1) cover image

Export Article

Open AccessReview

Macrocyclic Compounds for Drug and Gene Delivery in Immune-Modulating Therapy

Department of Chemistry, Zhejiang University, Hangzhou 310028, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(9), 2097; https://doi.org/10.3390/ijms20092097
Received: 2 April 2019 / Revised: 24 April 2019 / Accepted: 25 April 2019 / Published: 28 April 2019
(This article belongs to the Special Issue Host-Guest Complexes)
  |  
PDF [3430 KB, uploaded 28 April 2019]
  |  

Abstract

For decades, macrocyclic compounds have been widely applied in various fields owing to essential physicochemical properties such as their rigid cyclic structures, geometric dimensions (diameter and height), hydrophobic cavity, and hydrophilic interface. This review is an attempt to summarize various research accomplishments involving macrocyclic compounds for drug and gene delivery in immune-modulating therapies: the structures and benefits of main host molecules, their mechanisms regulating the immune system from cell uptake to activation of dendritic cells and T helper lymphocytes, as well as their potential immunotherapy for different diseases. Macrocyclic compounds including cucurbiturils (CBs), calixarenes, pillararenes, cyclodextrins (CyDs), macrocyclic peptides and metallo-supramolecular compounds, have their own unique physicochemical properties and functional derivatizations that enable to improve the biocompatibility, responsiveness to stimuli, and effectiveness of immune-modulating therapy. Based on abundant clarifications of the biological immunity mechanisms, representative constructions of macrocyclic compounds for immune therapies have been conducted for the investigation of treatment of different diseases including cancer, atherosclerosis, Niemann-Pick type C1 disease (NPC1), diabetes, and inflammations. Although there are critical challenges that remain to be conquered, we believe the future of macrocyclic compounds in the immune-modulating therapy must be bright. View Full-Text
Keywords: macrocycliccompounds; drug and gene delivery; physicochemical properties; immunity mechanisms; immune-modulating therapy macrocycliccompounds; drug and gene delivery; physicochemical properties; immunity mechanisms; immune-modulating therapy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Bai, H.; Wang, J.; Li, Z.; Tang, G. Macrocyclic Compounds for Drug and Gene Delivery in Immune-Modulating Therapy. Int. J. Mol. Sci. 2019, 20, 2097.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top